GeneticistHeladio Ibargüen

Mr. Heladio Ibargüen is a Colombian Geneticist and researcher born in Buenaventura who currently works for MD Anderson Cancer Center ranked consistently as one of the most important cancer research center in the world.
He is also a researcher at the Human Genetic Center of the University of Texas, School of Public Health in Houston,TX.


Mr. Ibargüen is one of the founders and currently the president of Cascajal Foundation. As the president, Mr. Ibargüen is committed to make Cascajal Foundation an important source of educational opportunities and guidance for young Latinos around US.


Mr. Ibargüen studied his high school at the school Pascual De Andogoya in Buenaventura and graduated with a Biology degree from la Universidad del Valle, where he gained his passion for genetics which led him to study and successfully graduate with a Masters degree in Genetics from the School of Medicine of Universidad Nacional De Colombia in Bogota. He was one of the pioneers scientist to study the Cancer genetics in Colombia. His excellent thesis work titled "Correlation between Chromosomic Abnomarlities and their prognosis in cancer patients" earned him the National Award of Internal Medicine in Cartagena, Colombia in 1988.


Mr. Ibargüen has been awarded several distinctions for his valuable contributions to science among the most important is the Award for Hispanic of the Year 2009 in Houston, Texas.


READ MORE ONLINE
causes
causes
causes

Dr. Ibargüen Interviews & Talks

CLICK TO PLAY

Research and Publications

Mr. Ibargüen has published over 16 papers Cancer Genetics through out his career as researcher:

  1. Cuero, R. and H. Ibarguen. 2016. Molecular and toxicological characterization of anti-UV Yeast plasmid compound for skin protection. Front Nanosci Nanotech. 2016; 2(4):159-164
  2. James E. Hixson; Lawrence C. Shimmin; May E. Montasser; Do-Kyun Kim; Yu Zhong; Heladio Ibarguen; et al. Common Variants in the Periostin Gene Influence Development of Atherosclerosis in Young Persons. Arteriosclerosis, Thrombosis, and Vascular Biology.2011;31:1661-1667.
  3. Hittelman WN, Liu DD, Kurie JM, Lotan R, Lee JS. Khuri F, Ibarguen H, Minna J. et al. Proliferative changes in the bronchial epithelium of former smokers treated with retinoids. J Natl Cancer Inst 2007; 99:1603-12
  4. Hixson J, Shimmin L, Natarajan S, Ibarguen H. Corticotropin Releasing Hormone (CRH) Gene Variation: Comprehensive resequencing for variant and molecular haplotype discovery in monosomic hybrid cell lines. DNA Sequence 2007;18(6):434-444.
  5. Papadimitrakopoulou V. Liu D. Mao L. Shin DM. El-Naggar A. Ibarguen H. Lee JJ, Hong WK, Hittelman WN. Biologic Correlates of a Biochemoprevention Trial in Advanced Upper Aerodigestive Tract Premalignant Lesions. Cancer Epidemiology. Biomarkers & Prevention. 2002; 11:1605-10
  6. Cuero, R. and H. Ibarguen. 2002. Metal Ions Mediation of Fungal Metabolism and Genetic Expression in Relation to Cytotoxicity and Toxigenicity in Human and Animals. In: Molecular and Cellular Biochemistry 222, 1-229, 2001. Proceedings. Second Conference on Molecular Mechanisms of Metal Toxicity and Carcinogenesis. September 8-11, 2002, Morgantown, W. Virginia

READ PDF VERSION OR READ MORE ONLINE
causes
causes